Bank of America’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
VPM
ACH
VCM
GKIM
DCM
Bank of America's TNDM Position: Q1 2026 in Review
Bank of America reduced its Tandem Diabetes Care (TNDM) stake by 47% in Q1 2026, selling an estimated $7.15M and leaving 373,224 shares worth $7.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3200.
Bank of America first reported a position in TNDM in Q4 2013 and has held it in 50 quarters since. The position peaked at $25.5M in Q2 2024. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.
- Bank of America held 373,224 shares of Tandem Diabetes Care worth $7.15M as of Q1 2026.
- Bank of America sold 329,279 Tandem Diabetes Care shares in Q1 2026, an estimated $7.15M.
- Tandem Diabetes Care made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3200 holding.
- Bank of America first reported a position in Tandem Diabetes Care in Q4 2013 and has held it in 50 quarters since.
- Bank of America's Tandem Diabetes Care position peaked at $25.5M in Q2 2024.
- 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.